StocksRunner logo
mail
search
 
menu
 
West Pharmaceutical
$302.04
-1.69%
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 

WST Stock Analysis & IQ Rating | West Pharmaceutical

 
 
 

WST

 

West Pharmaceutical

$302.04

 
-$5.18 | -1.69%
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
52W High
$ 348.9
 
 
MKT CAP
$ 21.72B
 
52W Low
$ 187.43
 
 
VOL
$ 306.69K
 
P/E Ratio
44.75
 
 
AVG VOL
$ 698.01K
 
RSI
76.80
 
 
TREND
Sideways
 
 
 

WST Stock IQ

 
lock  Login to see West Pharmaceutical (WST) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

WST Target Price

 
 
 

Strengths

 

WST Rewards

 Earnings are forecast to grow

WST Rewards

 Upgraded on attractively valued

 
 

Chart

 
 

$262.33   (+15.14%)

$244.05   (+23.76%)

$211.45   (+42.84%)

$323.93   (-6.76%)

 
 
1year
6month
3month
1month
 

WST Risk Level

 

WST has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

 
 

Risks Indicators

 

 Beta greater than 1.0

 
 
WST Risk Level
LOW
HIGH
 

WST Analysts Opinion

 

WST overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 

WST Earnings Sentiment

 Above analyst estimates

WST Earnings Sentiment

 Eps growth

 
 

Rating

×
 

Rating

 

WST Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

WST Momentum Analysis

 Price value has negative momentum

 

Activity

×
 

Activity

 
 

Future

×
 

Future

 

WST Future Sentiment

 Earnings are forecast to grow

 
 

WST Analysts Opinion

WST Analysts opinion is negative and has getting worse from the past 3 months

 

WST Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
83%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
50%
83%
70%
 

WST Street Opinion 

WST Street view is extremely bullish and have positive views on the near-term outlook

 

WST Performance Sentiment

 
Sentiments overview associated with WST events and the stock performance.
 
83%
17%
Positive
Negative
24 out of 29
events present
5 out of 29
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

WST Earnings

 

The TTM reflects 12-month period, providing review of WST financial performance.

 
Millions of Dollars
TTM
2024
2023
CAGR
 

 
Total Revenue
2,960
2,893
2,950
+0.17%
 
 
Cost of Revenue
1,916
1,895
1,821
+2.58%
 
 
Gross Profit
1,044
999
1,129
-3.84%
 
 
Operating Exp
422
408
422
-
 
 
Operating Inc
622
591
707
-6.20%
 
 
Net Interest Inc
17
17
19
-5.41%
 
 
Interest Exp
3
9
-
 
 
Interest Inc
17
20
28
-22.08%
 
 
Other Inc Exp
-42
-22
-28
-
 
 
EPS Growth
6.72
6.75
7.98
-8.23%
 
 

WST Financial Health

 

The company financial health has shown minor improvement, but significant issues remain

 

Financial Score

 
2.82
 
Next Earnings Date: Oct 23, 2025
 
 
WST Latest Analysis +
 
 
FAQ About WST Stock Insights
 

What is WST current stock price?

What are WST stock strengths?

What risks are associated with WST stock?

When is WST next earnings report?

What is WST market cap and volume?

What is WST's current Stock IQ?

Should I buy WST stock right now?

Is WST a Strong Buy right now?

What does a 'Strong Buy' rating mean for WST?

What does a 'Strong Sell' rating mean for WST?

What factors influence WST's Stock IQ?

 
 
StocksRunner

Explore our WST Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored WST Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our WST Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Earnings
 
StocksRunner Leaders
mail
 
 

WST

 

West Pharmaceutical

 
 

Current Price

 

$302.04

 
-$5.18 | -1.69%
 
 
52W High
$ 348.9
 
 
MKT CAP
$ 21.72B
 
52W Low
$ 187.43
 
 
VOL
$ 306.69K
 
P/E Ratio
44.75
 
 
AVG VOL
$ 698.01K
 
RSI
76.80
 
 
TREND
Sideways
 
 
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
 
 
 
 

Target Price

 
 
 
 
Not Enough Information
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

WST Rewards

 Earnings are forecast to grow

WST Rewards

 Upgraded on attractively valued

 
 
 
 
 

WST Stock IQ

 
lock  Login to unlock West Pharmaceutical (WST) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 

Chart

 
 

$262.33   (+15.14%)

$244.05   (+23.76%)

$211.45   (+42.84%)

$323.93   (-6.76%)

 
 
1year
6month
3month
1month
 

WST Analysts Opinion

 

WST Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 

WST Earnings Sentiment

 Above analyst estimates

WST Earnings Sentiment

 Eps growth

 
 

Rating

×
 

Rating

 

WST Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

WST Momentum Sentiment

 Price value has negative momentum

 

Activity

×
 

Activity

 
 

Future

×
 

Future

 

WST Future Sentiment

 Earnings are forecast to grow

 
 

WST Analysts Opinion

WST Analysts opinion is negative and has getting worse from the past 3 months

 

WST Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
83%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
50%
83%
70%
 

WST Street Opinion 

WST Street view is extremely bullish and have positive views on the near-term outlook

 

WST Risk Level

 

WST has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

 
 

Risks Indicators

 

 Beta greater than 1.0

 
 
WST Risk Level
LOW
HIGH
 
WST Performance Sentiment
 
Sentiments overview associated with WST events and the stock performance.
 
83%
17%
Positive
Negative
24 out of 29
events present
5 out of 29
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

WST Earnings

 

The TTM data reflects the most recent 12-month period, providing overview of WST financial performance.

 
Millions of Dollars
TTM
2024
2023
CAGR
 

 
Total Revenue
2,960
2,893
2,950
+0.17%
 
 
Cost of Revenue
1,916
1,895
1,821
+2.58%
 
 
Gross Profit
1,044
999
1,129
-3.84%
 
 
Operating Exp
422
408
422
-
 
 
Operating Inc
622
591
707
-6.20%
 
 
Net Interest Inc
17
17
19
-5.41%
 
 
Interest Exp
3
9
-
 
 
Interest Inc
17
20
28
-22.08%
 
 
Other Inc Exp
-42
-22
-28
-
 
 
EPS Growth
6.72
6.75
7.98
-8.23%
 
 

WST Financial Health

 

The company financial health has shown minor improvement, but significant issues remain

 

Financial Score

 
2.82
 
Next Earnings Date: Oct 23, 2025
 
 
 
 
 

WST Latest Analysis

 
 
 

West Pharmaceutical Services Inc. (NYSE:WST) Q3 2025 Earnings Call Transcript. West Pharmaceutical Services Inc. (NYSE:WST) Q3 2025 Earnings Call Transcript October 23 2025 West Pharmaceutical Services Inc. beats earnings expectations. Reported EPS is $1.96 expectations were $1.67. Operator: Good day and welcome to West’.s Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder this call may be recorded. I would now like to [….]

 

Today

$302.04 | -1.69%
 
Earnings

Evercore ISI Group Maintains West Pharmaceutical Services (WST) Outperform Recommendation. Fintel reports that on October 23 2025 Evercore ISI Group maintained coverage of West Pharmaceutical Services (NYSE:WST) with a Outperform recommendation. Analyst Price Forecast Suggests 4.22% Upside

 

Today

$302.04 | -1.69%
 
Rating

West to Participate in Upcoming Investor Conferences. EXTON Pa. Oct. 24 2025 /PRNewswire/ -- West Pharmaceutical Services Inc. (NYSE: WST) a global leader in innovative solutions for injectable drug administration today announced that it will present at the following upcoming investor conferences: UBS Global Healthcare Conference:...

 

Today

$302.04 | -1.69%
 
Activity

Why West Pharmaceutical Services Stock Was Blasting Higher on Thursday. Key PointsIt was a beat-and-raise third quarter for the healthcare services specialist.

 

Thu Oct 23, 2025

$307.25 | +11.01%
 
Momentum

West Pharmaceutical raises 2025 EPS guidance to $7.06-$7.11 amid strong HVP Components growth.

 

Thu Oct 23, 2025

$307.25 | +11.01%
 
Potential

West Pharma Soars After Q3 Beat Lifts Outlook On GLP-1 Demand. WST) shares surged Thursday after the injectable pharmaceutical packaging and delivery systems company’.s third-quarter 2025 earnings surpassed analyst estimates.West Pharmaceutical reported adjusted earnings of $1.96 per share beating the consensus of $1.68.Net sales of $804.6 million increased 7.7% year over year with organic growth was 5.0% beating the consensus of $787.93 million.“.Our strength was broad-based across bo

 

Thu Oct 23, 2025

$307.25 | +11.01%
 
Momentum
Potential

S&P 500 Movers: MOH WST. In early trading on Thursday shares of West Pharmaceutical Services topped the list of the days best performing components of the S&.P 500 index trading up 15.5%. Year to date West Pharmaceutical Services has lost about 2.3% of its value.And the worst performing S&

 

Thu Oct 23, 2025

$307.25 | +11.01%
 
Momentum
Momentum

WST Stock Up on Q3 Earnings Beat EPS View Raised on Demand & FX Benefit. West Pharmaceuticals strong Q3 beat and raised EPS outlook highlight robust demand FX tailwinds and solid growth in Proprietary Products.

 

Thu Oct 23, 2025

$307.25 | +11.01%
 
Earnings
Momentum
Potential

West Pharmaceutical Non-GAAP EPS of $1.96 beats by $0.27 revenue of $804.6M beats by $16.9M.

 

Thu Oct 23, 2025

$307.25 | +11.01%
 
Earnings

West Reports Third-Quarter 2025 Results. - Delivered solid growth across Proprietary Products and Contract Manufacturing Segments - - Achieved double-digit growth in HVP Components -- Strengthened executive leadership team including recently appointed CFO - Increases Full-Year 2025 Revenue and EPS Guidance - Third-Quarter Summary (comparisons to prior-year period)Net sales of Diluted EPS of Adjusted-diluted EPS of Full-year 2025 net sales guidance increased to a range of Full-year 2025 adjust

 

Thu Oct 23, 2025

$307.25 | +11.01%
 
Activity
Potential
Potential

 
 
 
 
 
StocksRunner

Discover WST Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of WST. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our WST Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

WST Stock trends

WST Stock performance

WST Stock analysis

WST investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

WST Runner Alarm

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 

 
 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing WST

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing WST

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.